Interestingly, in this cohort, ZEB1 expression was higher in BRAFV600 or NRASQ61R‐mutated melanomas compared to BRAF/NRAS WT tumors (Appendix Fig S2), which corroborates the involvement of the MAPK pathway in the regulation of ZEB1. Here, NRAS is linked to melanoma.